2011
DOI: 10.1016/j.ejphar.2011.02.019
|View full text |Cite
|
Sign up to set email alerts
|

Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 32 publications
(29 citation statements)
references
References 30 publications
2
24
0
3
Order By: Relevance
“…Furthermore, increased myocardial PPARα activity has been associated with improved adaptation to hyperglycemia and hyperlipidemia-induced metabolic disturbances [17]. In our experiment, increases in the expression of PPARα, γ, and δ in the AAR correlated with rising total cholesterol and LDL:HDL ratio.…”
Section: Discussionsupporting
confidence: 54%
“…Furthermore, increased myocardial PPARα activity has been associated with improved adaptation to hyperglycemia and hyperlipidemia-induced metabolic disturbances [17]. In our experiment, increases in the expression of PPARα, γ, and δ in the AAR correlated with rising total cholesterol and LDL:HDL ratio.…”
Section: Discussionsupporting
confidence: 54%
“…At the same time, mildronate, which decreases the blood glucose concentration in mice and diabetic rats, usually does not affect plasma insulin and C-peptide levels (Liepinsh et al, 2008;Liepinsh et al, 2009b). In addition, in study in Zucker rats mildronate along with decrease in glucose concentration also decreased pathologically elevated insulin concentration in fed Zucker rats (Liepinsh et al, 2011b). Moreover, mildronate induces a statistically significant 35% increase in insulin-stimulated glucose uptake in isolated mouse hearts (Liepinsh et al, 2008).…”
Section: Effects On Insulin Signallingmentioning
confidence: 87%
“…In obese Zucker rats, mildronate induced a moderate increase in the FA and TG concentrations, and it significantly improved insulin sensitivity and reduced blood glucose and insulin concentrations (Fig. 5C) (Liepinsh et al, 2011b). Thus, mildronate treatment, by www.intechopen.com …”
Section: Metabolic Flexibility and Protection Against Lipid Overloadmentioning
confidence: 99%
See 2 more Smart Citations